Zobrazeno 1 - 10
of 3 161
pro vyhledávání: '"F, Barkhof"'
Autor:
T. Numan, S. D. Kulik, B. Moraal, J. C. Reijneveld, C. J. Stam, P. C. de Witt Hamer, J. Derks, A. M. E. Bruynzeel, M. E. van Linde, P. Wesseling, M. C. M. Kouwenhoven, M. Klein, T. Würdinger, F. Barkhof, J. J. G. Geurts, A. Hillebrand, L. Douw
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Non-invasively measured brain activity is related to progression-free survival in glioma patients, suggesting its potential as a marker of glioma progression. We therefore assessed the relationship between brain activity and increasing tumor
Externí odkaz:
https://doaj.org/article/db7a744192a044f1a2cdce3407df8c2d
Autor:
M. van de Beek, I. van Steenoven, J. J. van der Zande, I. Porcelijn, F. Barkhof, C. J. Stam, P. G. H. M. Raijmakers, P. Scheltens, C. E. Teunissen, W. M. van der Flier, A. W. Lemstra
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-13 (2021)
Abstract Background The DEmEntia with LEwy bOdies Project (DEvELOP) aims to phenotype patients with dementia with Lewy bodies (DLB) and study the symptoms and biomarkers over time. Here, we describe the design and baseline results of DEvELOP. We inve
Externí odkaz:
https://doaj.org/article/e791df94bbb647a99215326a9d382377
Autor:
Nick A. Weaver, Lei Zhao, J. Matthijs Biesbroek, Hugo J. Kuijf, Hugo P. Aben, Hee‐Joon Bae, Miguel Á.A. Caballero, Francesca M. Chappell, Christopher P.L.H. Chen, Martin Dichgans, Marco Duering, Marios K. Georgakis, Ruben S. van derGiessen, Bibek Gyanwali, Olivia K.L. Hamilton, Saima Hilal, Elise M. vomHofe, Paul L.M. deKort, Peter J. Koudstaal, Bonnie Y.K. Lam, Jae‐Sung Lim, Stephen D.J. Makin, Vincent C.T. Mok, Lin Shi, Maria C. Valdés Hernández, Narayanaswamy Venketasubramanian, Joanna M. Wardlaw, Frank A. Wollenweber, Adrian Wong, Xu Xin, Meta VCI Map consortium, C. DeCarli, E.A. Fletcher, P. Maillard, J. Barnes, C.H. Sudre, J.M. Schott, M.A. Ikram, J.M. Papma, R.M.E. Steketee, M.W. Vernooij, R. Bordet, R. Lopes, C.‐W. Huang, R. Frayne, C.R. McCreary, E.E. Smith, Calgary Normative Study group, W. Backes, S. Köhler, R.J. vanOostenbrugge, J. Staals, F. Verhey, C.Y. Cheng, R.N. Kalaria, D. Werring, J.L. Hsu, K.‐L. Huang, J. van derGrond, J.W. Jukema, R.C. van derMast, T.C.W. Nijboer, Framingham Heart Study group, K.‐H. Yu, The Dutch Parelsnoer Institute – Neurodegenerative diseases group, R. Schmidt, L. Pirpamer, B.J. MacIntosh, A.D. Robertson, F.‐E. deLeeuw, A.M. Tuladhar, N. Chaturvedi, T. Tillin, H. Brodaty, P. Sachdev, TABASCO group, F. Barkhof, W.M. van derFlier, L.J. Kappelle, Geert Jan Biessels
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 310-326 (2019)
Abstract Introduction The Meta VCI Map consortium performs meta‐analyses on strategic lesion locations for vascular cognitive impairment using lesion‐symptom mapping. Integration of data from different cohorts will increase sample sizes, to impro
Externí odkaz:
https://doaj.org/article/1aa346e2b88b413ba69d2ca3bb78ab8c
Autor:
O. Goodkin, F. Prados, S.B. Vos, H. Pemberton, S. Collorone, M.H.J. Hagens, M.J. Cardoso, T.A. Yousry, J.S. Thornton, C.H. Sudre, F. Barkhof
Publikováno v:
NeuroImage: Clinical, Vol 29, Iss , Pp 102542- (2021)
Background: MRI assessment in multiple sclerosis (MS) focuses on the presence of typical white matter (WM) lesions. Neurodegeneration characterised by brain atrophy is recognised in the research field as an important prognostic factor. It is not rout
Externí odkaz:
https://doaj.org/article/3910c8da7806466ba7054711e1211bad
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E.E. Wolters, M. van de Beek, R. Ossenkoppele, S.S.V. Golla, S.C.J. Verfaillie, E.M. Coomans, T Timmers, D. Visser, H. Tuncel, F. Barkhof, R. Boellaard, A.D. Windhorst, W.M. van der Flier, Ph. Scheltens, A.W. Lemstra, B.N.M. van Berckel
Publikováno v:
NeuroImage: Clinical, Vol 28, Iss , Pp 102504- (2020)
Purpose: Alpha-synuclein often co-occurs with Alzheimer’s disease (AD) pathology in Dementia with Lewy Bodies (DLB). From a dynamic [18F]flortaucipir PET scan we derived measures of both tau binding and relative cerebral blood flow (rCBF). We teste
Externí odkaz:
https://doaj.org/article/1d07629532ed42929eeae18f1a5bd895
Autor:
E.M.E. Coerver, A. Bourass, M.H.J. Wessels, Z.L.E. van Kempen, M.M.S. Jasperse, B.A.R. Tonino, F. Barkhof, J. Mostert, B.M.J. Uitdehaag, J. Killestein, E.M.M. Strijbis
Publikováno v:
Multiple Sclerosis and Related Disorders, 74:104706. Elsevier
Coerver, E M E, Bourass, A, Wessels, M H J, van Kempen, Z L E, Jasperse, M M S, Tonino, B A R, Barkhof, F, Mostert, J, Uitdehaag, B M J, Killestein, J & Strijbis, E M M 2023, ' Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis ', Multiple Sclerosis and Related Disorders, vol. 74, 104706 . https://doi.org/10.1016/j.msard.2023.104706
Coerver, E M E, Bourass, A, Wessels, M H J, van Kempen, Z L E, Jasperse, M M S, Tonino, B A R, Barkhof, F, Mostert, J, Uitdehaag, B M J, Killestein, J & Strijbis, E M M 2023, ' Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis ', Multiple Sclerosis and Related Disorders, vol. 74, 104706 . https://doi.org/10.1016/j.msard.2023.104706
BACKGROUND: It is not known if and when first-line disease modifying therapy (DMT) can safely be discontinued in relapse onset multiple sclerosis (MS) patients.OBJECTIVES: To investigate the characteristics of patients who discontinued first-line DMT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e6ed05076484f941d12721ec6d4b8f
https://research.vumc.nl/en/publications/6934b4a4-1e47-4962-b6dc-3a57e7ffca64
https://research.vumc.nl/en/publications/6934b4a4-1e47-4962-b6dc-3a57e7ffca64
Autor:
P.M. Cogswell, J.A. Barakos, F. Barkhof, T.S. Benzinger, C.R. Jack, T.Y. Poussaint, C.A. Raji, V.K. Ramanan, C.T. Whitlow
Publikováno v:
American Journal of Neuroradiology, 43(9), E19-E35. American Society of Neuroradiology
Cogswell, P M, Barakos, J A, Barkhof, F, Benzinger, T S, Jack, C R, Poussaint, T Y, Raji, C A, Ramanan, V K & Whitlow, C T 2022, ' Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics : Detection and Reporting Recommendations for Clinical Practice ', American Journal of Neuroradiology, vol. 43, no. 9, pp. E19-E35 . https://doi.org/10.3174/ajnr.A7586
Cogswell, P M, Barakos, J A, Barkhof, F, Benzinger, T S, Jack, C R, Poussaint, T Y, Raji, C A, Ramanan, V K & Whitlow, C T 2022, ' Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics : Detection and Reporting Recommendations for Clinical Practice ', American Journal of Neuroradiology, vol. 43, no. 9, pp. E19-E35 . https://doi.org/10.3174/ajnr.A7586
SUMMARY: Monoclonal antibodies are emerging disease-modifying therapies for Alzheimer disease that require brain MR imaging for eligibility assessment as well as for monitoring for amyloid-related imaging abnormalities. Amyloid-related imaging abnorm
Autor:
F. Bartel, M. Visser, M. de Ruiter, J. Belderbos, F. Barkhof, H. Vrenken, J.C. de Munck, M. van Herk
Publikováno v:
NeuroImage: Clinical, Vol 23, Iss , Pp - (2019)
Objective: To compare the performance of different methods for determining hippocampal atrophy rates using longitudinal MRI scans in aging and Alzheimer's disease (AD). Background: Quantifying hippocampal atrophy caused by neurodegenerative diseases
Externí odkaz:
https://doaj.org/article/ae19000f399a4e209c40bbd2f4b50429
Autor:
M.M. Weeda, S.M. Middelkoop, M.D. Steenwijk, M. Daams, H. Amiri, I. Brouwer, J. Killestein, B.M.J. Uitdehaag, I. Dekker, C. Lukas, B. Bellenberg, F. Barkhof, P.J.W. Pouwels, H. Vrenken
Publikováno v:
NeuroImage: Clinical, Vol 24, Iss , Pp - (2019)
Introduction: Atrophy of the spinal cord is known to occur in multiple sclerosis (MS). The mean upper cervical cord area (MUCCA) can be used to measure this atrophy. Currently, several (semi-)automated methods for MUCCA measurement exist, but validat
Externí odkaz:
https://doaj.org/article/1893920b04e94aacaa84b77c28e356ad